Skip to main content
. 2017 May 26;158(1):213–226. doi: 10.1093/toxsci/kfx082

Figure 1.

Figure 1

Small molecule kinase inhibitors affect human induced pluripotent stem cell-derived cardiomyocytes beating function at concentrations that do not affect cell viability. Changes in beat rate (BR), amplitude (AMP), cell index (CI), and cellular ATP levels expressed as percent control of hiPSC CM treated with 3 µM of compounds for 2 h (BR and AMP) or 24 h (CI and ATP). Points are representative of the mean of at least three independent experiments. Only those compounds that had an effect on BR or AMP are shown.